GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.